Newormics, LLC

AI-powered whole-organism toxicology screening platform

Built from URL

Austin

HealthcareMachine LearningAutomationLife SciencesAIBiotechDrug Discovery

MassChallengeTexas 2018

AboutBuilt from URL

vivoVerse develops AI-powered whole-organism screening technology for toxicology testing using C. elegans model systems. Their vivoDART assay provides developmental and reproductive toxicity testing that is 15x faster and 50x lower cost than mammalian assays, running on their automated vivoScreen platform with patented vivoChip microfluidic technology.

ProblemBuilt from URL

See something off about this company?